The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori R… (NCT06292546) | Clinical Trial Compass
CompletedNot Applicable
The Effects of High-dose Dual Therapy With Probiotics on Gut Microbiota for Helicobacter Pylori Rescue Treatment
China72 participantsStarted 2024-01-31
Plain-language summary
The aim of this study was to evaluate the effects of High-dose Dual therapy combined with probiotics on the gut microbiota for Helicobacter pylori rescue treatment.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age from 18 to 65 years;
* H.pylori infection diagnosed by 13C-urea breath test;
* A period of more than two months since the last eradication therapy for H. pylori;
* Patients who had previously failed 2 or more eradication regimens.
Exclusion Criteria:
* Allergy to any of the medications;
* Zollinger-Ellison syndrome, GC, Upper gastrointestinal bleeding, or Active peptic ulcer;
* Coexistence of significant concomitant illnesses, including heart disease, renal failure, hepatic disease, previous abdominal surgery, lactation, or pregnancy;
* Patients who had used probiotics, vonoprazan, and antibiotics in the past 12 weeks;
* Unwillingness to participate in this study.
What they're measuring
1
Gut Microbiota
Timeframe: day 0, day 44 (or 58), day 104 (or 118)
Trial details
NCT IDNCT06292546
SponsorZhongshan Hospital (Xiamen), Fudan University